Metastatic pancreatic cancer signaling

ABSTRACT: Proteomic and signaling alterations among cells isolated from three sites of metastasis (liver, lung and peritoneum) from a single patient were studied using a SILAC-based quantitative proteomic strategy combined with a high resolution mass spectrometry.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

DISEASE(S): Pancreatic Ductal Adenocarcinoma

SUBMITTER: Akhilesh Pandey  

LAB HEAD: Min-Sik Kim

PROVIDER: PXD000750 | Pride | 2014-08-13

REPOSITORIES: Pride